http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NZ-705225-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0c509c10f7993bf4185abf29e4bf8d50
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J2231-344
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J2531-824
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J2231-4294
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J2231-4288
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J2231-4283
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J2231-4227
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J31-2423
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J31-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
filingDate 2011-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cbe421bb9c06bec6361a6b3c1b19bfd5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_782142feada1cf505ae20cb320453573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e70def82ca9db02dbf36eaf88cab5c96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ecfda85ac8623fb7ce237f754199f38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3463be99841bf1e711a83e8493a1c0da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_505abfe3b6ea5dc7f64fc35c01b16a38
publicationDate 2016-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber NZ-705225-A
titleOfInvention Process for preparing antiviral compounds
abstract Disclosed is a composition comprising the compound 1-(3-tert-butyl-5-(6-hydroxynaphthalen-2-yl)-4-methoxyphenyl)pyrimidine-2,4(1H,3H)-dione of formula (4) (or a salt therof), or the compound 6-(3-tert-butyl-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxyphenyl)naphthalen-2-yl 1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonate of formula (5a) (or a salt therof). Said compounds are useful intermediates for the synthesis of dasabuvir.
priorityDate 2010-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419905596
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56640670
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413252254
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56640146

Total number of triples: 40.